QuartzBio Team, Author at QuartzBio

About QuartzBio Team

This author has not written his bio yet.
But we are proud to say that QuartzBio Team contributed 72 entries already.

Entries by QuartzBio Team

Unleashing Innovative, AI/ML-Based Processes While Reducing Risks for Drug Development

AI/ML can be a powerful, error-reducing tool for managing clinical sample data as well as biomarker data.

AI/ML-based tools should not replace human judgment, particularly for insight generation, at least until AI/ML-based tools are extensively and rigorously validated (as any piece of critical software would be). Furthermore, regulatory compliance and data privacy are of utmost importance and must be considered when building and using solutions that leverage generative AI frameworks.

However, near-term applications of AI/ML can dramatically improve any tedious process involving a human inspecting data. We list some of these processes in the box below, along with steps we recommend taking to reduce risk in each case.

QuartzBio, a Part of Precision for Medicine, Acquires SolveBio and Expands Software-as-a-Service (SaaS) Data Management Solutions for Clinical Research & Development

Precision for Medicine, the first global, precision medicine, clinical research services organization today announced the strategic acquisition of SolveBio, which will now fall under the QuartzBio, part of Precision for Medicine brand and product portfolio.

Webinar: Clinical Sample Chaos – Tracking and Reporting Metrics Across Clinical Programs

Duration: 30 minutes Register to watch on demand: Complex sample operations, disparate vendors, inconsistent metadata across labs are common challenges sponsors face when keeping track of samples across clinical programs. Join our webinar to learn how sponsor teams are creating consistent, portfolio-level approaches for tracking sample status and location and uncovering insights into vendor/site/country-level performance.

Centralizing PK, Clinical, and Exploratory Data to Streamline Biomarker-Centric Trial Operations

December 10, 2020 — Biomarker-guided trials frequently have an international footprint of sites to reach targeted patient populations and involve a complex network of specialty labs. Join us for our upcoming webinar, where QuartzBio’s Tobi Guennel will discuss how his team is breaking down data siloes to create actionable insights into availability and quality of […]

Connecting Raw, Processed, and Ancillary Data with a Biomarker Data Management Solution

Translational and clinical teams spend more than 70% of their time managing, cleaning, and harmonizing data generated in biomarker-rich clinical programs. In a recent webinar, Adam Brown demonstrated how the QuartzBio® enterprise Biomarker Data Management (eBDM) solution addresses one set of frequently intractable challenges: connecting raw, processed, and ancillary data across multiple clinical studies.

How a Flexible Approach to ICF Codification Reduces Complexity

Biospecimens collected as part of biomarker-informed clinical programs are precious resources for precision medicine research and development (R&D). However, the complexity of tracking and linking informed consent data at the sample and derivative levels limits the use of these biospecimens. In this post, we’ll explore how clinical teams can benefit from QuartzBio’s flexible approach to ICF codification to reduce complexity, gain more value from their stored samples, and help turn their biorepositories into drug development engines.

Webinar: Overcoming Biomarker Data Chaos with a Single Data Platform

Duration: 30 minutes Register for the Webinar: Translational and clinical research teams spend more than 70% of their time wrangling information from disconnected clinical trial data sets. Data ends up in silos, making it hard to compile information and surface insights. Watch this short webinar, where Adam Brown and Mike Waters will demonstrate how integrating […]

4 Strategic Imperatives for Clinical and Biomarker Operations

Keeping track of clinical trial samples across multiple sites and vendors can be manual and tedious — we have demonstrated how Sample Intelligence can streamline the day-to-day reporting of sample collections, shipments, and discrepancies.

Webinar: Monitoring Site and Vendor Performance Metrics Across Studies

Duration: 30 minutes Register to Watch On Demand: Summary Clinical and translational teams must monitor biomarker samples across global site footprints and dispersed networks of labs and biorepositories. It’s easy to get bogged down by managing the day-to-day requirements of keeping studies on track. With samples as the critical first step toward data generation, modern […]

Streamlining vendor oversight: Monitoring site-level and laboratory performance across multiple oncology trials

The challenge: Maintaining clinical trial timelines dependent on vendor performance A global biotechnology company with seven clinical-phase programs approached QuartzBio with a challenge shared by many organizations in the industry — overall assessment of clinical trial vendors and sites was time-consuming and unreliable, given global site footprints, complex sample lifecycles, and inconsistent naming across sites […]